Published in Ter Arkh on January 01, 1986
[Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis]. Patol Fiziol Eksp Ter (1991) 0.84
[Dynamic changes in synovitis activity after intra-articular administration of xefocam in patients with rheumatoid arthritis (according to clinical and device examinations)]. Ter Arkh (2003) 0.84
[The mechanism of the action of laser therapy in rheumatoid arthritis]. Ter Arkh (1994) 0.83
[Corticosteroid therapy and aseptic bone necrosis in patients with rheumatoid arthritis]. Ter Arkh (1995) 0.78
[Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons]. Ter Arkh (2003) 0.78
Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol (1979) 0.76
[Human pathologies associated with mutations of mitochondrial genome]. Patol Fiziol Eksp Ter (2012) 0.76
[Prognosis and treatment of patients with systemic lupus erythematosus in different age groups]. Ter Arkh (1985) 0.75
[Present problems of neuroimmunology]. Vestn Ross Akad Med Nauk (1994) 0.75
[Diagnosis of lesions of the central nervous system in patients with systemic lupus erythematosus]. Revmatologiia (Mosk) (1992) 0.75
[Clinico-immunologic characteristics of complicated and uncomplicated yersiniosis]. Vestn Akad Med Nauk SSSR (1989) 0.75
[Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy]. Ter Arkh (2009) 0.75
[Clinico-genetic associations in systemic lupus erythematosus]. Ter Arkh (1981) 0.75
[Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)]. Vopr Revm (1982) 0.75
[Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation]. Ter Arkh (1983) 0.75
[Lesions of the central nervous system in systemic lupus erythematosus in the computerized-tomographic image]. Klin Med (Mosk) (1989) 0.75
[Clinical variants of the onset of early stage of infectious nonspecific (rheumatoid) arthritis]. Vopr Revm (1977) 0.75
[Gout]. Med Sestra (1984) 0.75
[Blood serum glycosaminoglycans in assessing the degree of activity in systemic lupus erythematosus]. Revmatologiia (Mosk) (1988) 0.75
[An assessment of tissue microcirculation in patients with aseptic femur head necrosis in rheumatoid arthritis]. Ter Arkh (1994) 0.75
[Age factors and basic therapy of rheumatoid arthritis]. Ter Arkh (1981) 0.75
[Results of long-term treatment of patients in the early stages of rheumatoid arthritis]. Revmatologiia (Mosk) (1986) 0.75
[Diclonate P in rheumatoid arthritis]. Ter Arkh (1994) 0.75
[The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term]. Ter Arkh (1996) 0.75
[Scientific bases of medical examinations of patients with rheumatic diseases]. Vestn Ross Akad Med Nauk (1998) 0.75
[Flurbiprofen: pharmacological characteristics and clinical effectiveness]. Klin Med (Mosk) (1998) 0.75
[Comparative results of the study of early stage of rheumatoid arthritis]. Vopr Revm (1978) 0.75
[Immunological aspects of pulse therapy in systemic lupus erythematosus]. Ter Arkh (1986) 0.75
[Treatment of joint diseases with dimethyl sulfoxide (DMSO) applications]. Ter Arkh (1979) 0.75
[Materials on approbation of diagnostic criteria in disseminated connective tissue diseases]. Ter Arkh (1978) 0.75
[The clinico-immunological characteristics of central nervous system involvement in systemic lupus erythematosus: the relationship with antibodies to cardiolipin]. Ter Arkh (1992) 0.75
[Human gastric mucosa under the effect of antirheumatic drugs - aspirin, indomethacin, brufen and prednisolone]. Vopr Revm (1976) 0.75
[Ultra-high (shock) doses of methylprednisolone in lupus nephritis]. Ter Arkh (1980) 0.75
[Rheumatoid arthritis with an onset in old age (a review of the literature)]. Vopr Revm (1980) 0.75
[Study of the peripheral blood lymphocytes in systemic lupus erythematosus of different degree of activity]. Ter Arkh (1978) 0.75
[Results of the 5-year treatment of early forms of rheumatoid arthritis]. Vopr Revm (1981) 0.75
[Current methods of treating acute gouty arthritis]. Ter Arkh (1981) 0.75
[Dispensary care of patients with systemic lupus erythematosus]. Med Sestra (1988) 0.75
[Clinical aspects and diagnosis of diffuse eosinophilic fasciitis]. Ter Arkh (1986) 0.75
[Effect of hemosorption on the course of autoimmune diseases with predominant involvement of the skin]. Klin Med (Mosk) (1982) 0.75
[Combined use of impact doses of 6-methylprednisolone and cyclophosphamide in patients with systemic lupus erythematosus]. Ter Arkh (1985) 0.75
[The effect of bemetil on the production of DNA antibodies in patients with systemic lupus erythematosus]. Eksp Klin Farmakol (1999) 0.75
[Mediastinal echinococcus]. Vopr Onkol (2003) 0.75
[Periodic disease associated with rheumatoid arthritis]. Vrach Delo (1978) 0.75
[Diagnostic possibilities of a test of blood neutrophil damage in various forms of yersiniosis in man]. Vestn Akad Med Nauk SSSR (1989) 0.75
[Clinical characteristics of rheumatoid arthritis and psoriatic arthropathy from the comparative viewpoint]. Revmatologiia (Mosk) (1985) 0.75
[Antibodies to extractable nuclear antigens in rheumatic diseases]. Ter Arkh (1980) 0.75
[Combined syndromes of diffuse connective tissue diseases]. Vopr Revm (1978) 0.75
[The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement]. Ter Arkh (1995) 0.75
[Rehabilitation of patients with gout during outpatient follow-up]. Ter Arkh (1987) 0.75
[Treatment of systemic lupus erythematosus]. Klin Med (Mosk) (1985) 0.75
[Hemoperfusion through activated charcoal in the complex treatment of systemic lupus erythematosus]. Ter Arkh (1981) 0.75
[Rheumatoid arthritis and related joint diseases (differential diagnosis and clinico-pathogenetic aspects)]. Ter Arkh (1983) 0.75
[Pachydermoperiostosis. A description of 2 cases]. Ter Arkh (1984) 0.75
[Circulating immune complexes and clinico-immunologic subtypes of systemic lupus erythematosus. II]. Ter Arkh (1989) 0.75
[Active forms of oxygen and pathogenesis of rheumatoid arthritis and systemic lupus erythematosus]. Vestn Ross Akad Med Nauk (1996) 0.75
[CNS lupus: problems and achievements (results of a 10-year clinical and instrumental study) (lecture)]. Ter Arkh (2001) 0.75
[Pseudosclerodermic conditions]. Ter Arkh (1976) 0.75
[Cerebral vasculitis complicated with ruptured aneurysm of the basilar artery in a patient with systemic lupus erythematosus]. Klin Med (Mosk) (1993) 0.75
[Quantitative characteristic of circulating immune complexes in patients with lupus erythematosus and central nervous system disorders]. Klin Med (Mosk) (1991) 0.75
[Variants of Bechterew's disease]. Ter Arkh (1980) 0.75
[Study of rheumatic diseases and international cooperation]. Vopr Revm (1979) 0.75
[Diagnostic criteria of systemic lupus erythematosus]. Sov Med (1980) 0.75
[Systemic lupus erythematosus with involvement of the central nervous system]. Klin Med (Mosk) (1989) 0.75
[Mixed connective tissue disease]. Ter Arkh (1982) 0.75
[Course of infectious nonspecific (rheumatoid) polyarthritis with onset at advanced age]. Vopr Revm (1978) 0.75
[Effect of cytotoxic immunosuppressive agents on the level of urinary seromucoids and cathepsins in lupus nephritis]. Ter Arkh (1980) 0.75
[Articular syndrome at early stages of rheumatoid arthritis, systemic scleroderma and infectious-allergic syndrome]. Sov Med (1977) 0.75
[Advances and prospects in the treatment of systemic lupus erythematosus]. Ter Arkh (2009) 0.75
[Intravenous administration of high doses (pulse therapy) of methylprednisolone in lupus nephritis]. Ter Arkh (1983) 0.75
[Rheumatoid arthritis (problems of diagnosis and the course of an early stage)]. Ter Arkh (1979) 0.75
[An a typical variant of Bechterew's disease: ankylosing panarthritis?]. Ter Arkh (1988) 0.75
[Soviet-American cooperation on the problem of arthritides]. Vopr Revm (1980) 0.75
[Nephropathy in a patient with systemic scleroderma treated with D-penicillamine]. Ter Arkh (1980) 0.75
[An evaluation of the results of the long-term treatment of rheumatoid arthritis patients with gold salts, aminoquinoline preparations and nonsteroidal anti-inflammatory preparations]. Ter Arkh (1997) 0.75
[Basic methods of treatment of and individual programs for patients with systemic lupus erythematosus]. Klin Med (Mosk) (2000) 0.75
[Deforming hand arthropathy in systemic lupus erythematosus]. Klin Med (Mosk) (2002) 0.75
[Secretory function of the stomach in rheumatic patients and the effect of complex hormon therapy]. Vrach Delo (1968) 0.75
[Clinico-instrumental methods of diagnosing aseptic femur head necrosis in patients with systemic lupus erythematosus]. Ter Arkh (1988) 0.75
[Comparative study of DNA-repair ability of lymphocytes from systemic lupus erythematosus and rheumatoid arthritis patients]. Genetika (1997) 0.75
[Diffuse connective tissue diseases and malignant tumors]. Klin Med (Mosk) (1985) 0.75
[The results of the dynamic observation of patients with reactive Yersinia arthritis]. Ter Arkh (1991) 0.75
[Clinical variants of early stages of systemic scleroderma]. Ter Arkh (1975) 0.75
[Immunomorphological changes in the skin of patients with systemic lupus erythematosus and the effect of cytostatic therapy]. Ter Arkh (1981) 0.75
[Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants]. Ter Arkh (1980) 0.75
[Diffuse eosinophilic fasciitis]. Ter Arkh (1978) 0.75
[Circulating immune complexes (PEG tests) in systemic lupus erythematosus]. Ter Arkh (1982) 0.75
[The rheumatic complications of pseudotuberculosis in a newly arrived population in Siberia]. Ter Arkh (1991) 0.75
[Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment]. Revmatologiia (Mosk) (1983) 0.75
[Electrolytes of the blood and gastric juice in rheumatism and their changes under the effect of combined hormone-drug therapy]. Vopr Revm (1970) 0.75
[Natural cytotoxicity in systemic lupus erythematosus patients]. Ter Arkh (1984) 0.75
[Echodiagnosis of the kidney lesion in gout]. Ter Arkh (1986) 0.75
[Significance of damage index in predicting systemic lupus erythematosus outcome]. Ter Arkh (2003) 0.75
[Characteristics of the immune complex process in patients with systemic lupus erythematosus with predominant kidney involvement]. Ter Arkh (1986) 0.75
[Study of DNA damage of blood mononuclear cells in patients with systemic lupus erythematosus by the method of DNA-comets]. Biull Eksp Biol Med (1998) 0.75
[Use of brufen in rheumatological practice]. Ter Arkh (1976) 0.75